These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39379951)

  • 1. The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial.
    Ostadrahimi A; Khajebishak Y; Moradi F; Payahoo L
    BMC Endocr Disord; 2024 Oct; 24(1):210. PubMed ID: 39379951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M
    Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleoylethanolamide increases the expression of PPAR-Α and reduces appetite and body weight in obese people: A clinical trial.
    Laleh P; Yaser K; Abolfazl B; Shahriar A; Mohammad AJ; Nazila F; Alireza O
    Appetite; 2018 Sep; 128():44-49. PubMed ID: 29787831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome.
    Shivyari FT; Pakniat H; Nooshabadi MR; Rostami S; Haghighian HK; Shiri-Shahsavari MR
    J Ovarian Res; 2024 May; 17(1):111. PubMed ID: 38778429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial.
    Payahoo L; Khajebishak Y; Alivand MR; Soleimanzade H; Alipour S; Barzegari A; Ostadrahimi A
    Appetite; 2019 Oct; 141():104301. PubMed ID: 31132422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial.
    Zeinalian R; Farhangi MA; Shariat A; Saghafi-Asl M
    BMC Complement Altern Med; 2017 Apr; 17(1):225. PubMed ID: 28431534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Tutunchi H; Mobasseri M; Pourmoradian S; Soleimanzadeh H; Kafil B; Akbari N; Monshikarimi A; Ostadrahimi A
    Trials; 2020 Oct; 21(1):890. PubMed ID: 33109244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial.
    Payahoo L; Khajebishak Y; Asghari Jafarabadi M; Ostadrahimi A
    Adv Pharm Bull; 2018 Aug; 8(3):479-487. PubMed ID: 30276145
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Satureja Khuzestanica supplementation on glycemic indices and lipid profile in type 2 diabetes patients: a randomized controlled clinical-trial.
    Roosta S; Ghasemi F; Mokhayeri Y; Choobkar S; Nikbakht MR; Falahi E
    BMC Complement Med Ther; 2024 May; 24(1):201. PubMed ID: 38778308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight/obese women with polycystic ovary syndrome (PCOS): a randomized, double-blind, placebo-controlled trial.
    Hooshmandi H; Ghadiri-Anari A; Ranjbar AM; Fallahzadeh H; Hosseinzadeh M; Nadjarzadeh A
    J Ovarian Res; 2024 Jul; 17(1):157. PubMed ID: 39080737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
    Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
    Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial.
    Dogay Us G; Mushtaq S
    Lipids Health Dis; 2022 Sep; 21(1):84. PubMed ID: 36050695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial.
    Ghanbarzadeh-Ghashti N; Ghanbari-Homaie S; Shaseb E; Abbasalizadeh S; Mirghafourvand M
    BMC Endocr Disord; 2023 Feb; 23(1):40. PubMed ID: 36788534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial.
    Fallah F; Mahdavi R
    Front Endocrinol (Lausanne); 2023; 14():1237882. PubMed ID: 37929031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet.
    Haidari F; Aghamohammadi V; Mohammadshahi M; Ahmadi-Angali K; Asghari-Jafarabadi M
    Trials; 2020 Jul; 21(1):657. PubMed ID: 32680548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.